Bart Frizzell
Papers
1
Total Citations
22
H-Index
1
About
Bart Frizzell is a leading clinical researcher in head and neck oncology, with a focused expertise in human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV+ OPSCC). His work directly addresses one of the most pressing questions in the field: how to optimize treatment to balance oncologic control with functional preservation. Frizzell’s most cited study, a 2023 investigation with 22 citations, provides a critical comparative analysis of primary transoral robotic surgery (TORS) versus radiotherapy (RT) in early-stage HPV+ OPSCC. By examining progression-free survival, overall survival, and—crucially—one-year swallowing function, this work offers actionable evidence for treatment de-escalation strategies. This contribution is particularly impactful for a disease affecting younger, healthier patients, where long-term quality of life is paramount. Through this research, Frizzell has helped clarify the trade-offs between surgical and radiation-based approaches, guiding multidisciplinary decision-making. His work underscores a commitment to not just curing cancer, but to preserving the functions that define daily life, cementing his reputation as a thoughtful voice in the evolution of personalized, function-sparing head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1